FDA
approval
· 2025-02-21
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for a buprenorphine and naloxone product manufactured by Mylan Pharmaceuticals Inc., expanding access to a generic formu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)